Crossmark

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Crossref DOI link: https://doi.org/10.1186/s40478-019-0687-5

Published Online: 2019-03-04

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gibbons, Garrett S.

Kim, Soo-Jung

Robinson, John L.

Changolkar, Lakshmi

Irwin, David J.

Shaw, Leslie M.

Lee, Virginia M.-Y.

Trojanowski, John Q.
Funding

Funding for this research was provided by:

National Institute on Aging (AG53036, AG17586, AG10224)

National Institute of Neurological Disorders and Stroke (NS088341)
License Information

Text and Data Mining valid from 2019-03-04

Version of Record valid from 2019-03-04
More Information

Article History

Received: 22 February 2019

Accepted: 23 February 2019

First Online: 4 March 2019

Ethics approval and consent to participate

: All procedures were performed with informed consent in accordance with state laws and institutional review board guidelines of the University of Pennsylvania.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below